Results 51 to 60 of about 4,792 (191)

Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients. [PDF]

open access: yesPLoS ONE, 2017
Numerous outcome studies and interventional trials in hemodialysis (HD) patients are based on uremic toxin concentrations determined at one single or a limited number of time points.
Sunny Eloot   +7 more
doaj   +1 more source

The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients

open access: yesScientific Reports, 2021
Protein-bound uremic toxins (Indoxyl sulfate [IS] and p-cresyl sulfate [PCS]) are both associated with cardiovascular (CV) and all-cause mortality in subjects with chronic kidney disease (CKD). Possible mechanisms have not been elucidated.
Ping-Hsun Wu   +10 more
doaj   +1 more source

Pyroptosis: A Common Feature of Immune Cells of Haemodialysis Patients

open access: yesToxins, 2021
NLRP-3 inflammasome activation can result in interleukin-1β (IL-1β) release and inflammatory cell death (pyroptosis). Caspase-1 is able to trigger both processes.
Christof Ulrich   +10 more
doaj   +1 more source

Review on uremic toxins : classification, concentration, and interindividual variability [PDF]

open access: yes, 2003
Background. The choice of the correct concentration of potential uremic toxins for in vitro, ex vivo, and in vivo experiments remains a major area of concern; errors at this level might result in incorrect decisions regarding therpeutic correction of ...
Thomas Henle   +47 more
core   +1 more source

Protein-bound uremic solutes: The forgotten toxins

open access: yesKidney International, 2001
The present concept of dialysis focuses mainly on the removal of small water-soluble compounds, and also, the currently applied kinetic parameters of dialysis adequacy are based on the behavior of water-soluble compounds. Nevertheless, many of the currently known biological effects in uremia are attributable to compounds with different physicochemical ...
Vanholder, Raymond   +2 more
openaire   +2 more sources

Adsorption- and Displacement-Based Approaches for the Removal of Protein-Bound Uremic Toxins

open access: yesToxins, 2023
End-stage renal disease (ESRD) patients rely on renal replacement therapies to survive. Hemodialysis (HD), the most widely applied treatment, is responsible for the removal of excess fluid and uremic toxins (UTs) from blood, particularly those with low molecular weight (MW < 500 Da).
Flávia S. C. Rodrigues, Mónica Faria
openaire   +3 more sources

Zirconium-Based Metal–Organic Frameworks for the Removal of Protein-Bound Uremic Toxin from Human Serum Albumin [PDF]

open access: yes, 2019
Uremic toxins often accumulate in patients with compromised kidney function, like those with chronic kidney disease (CKD), leading to major clinical complications including serious illness and death.
Haoyuan Chen   +15 more
core   +5 more sources

Protein-Bound Uremic Toxins: New Insight from Clinical Studies [PDF]

open access: yesToxins, 2011
The uremic syndrome is attributed to the progressive retention of a large number of compounds which, under normal conditions, are excreted by healthy kidneys. The compounds are called uremic toxins when they interact negatively with biological functions.
Sophie Liabeuf   +2 more
openaire   +3 more sources

Effects of uremic toxin p-cresol on oxidative stress in human coronary artery endothelial cells

open access: yesDi-san junyi daxue xuebao, 2021
Objective To investigate the effects of uremic toxin p-cresol (PC) on the oxidative stress of human coronary artery endothelial cells (HCAECs). Methods HCAECs were cultured in vitro, and treated with different concentrations of free PC alone or combined ...
LI Li, LI Jing, YUAN Fahuan, LI Xiaoli
doaj   +1 more source

Home - About - Disclaimer - Privacy